Clinical trialNCT01947946TerminatedPhase 3Interventional

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

SponsorAstraZenecaEnrollment13Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

William W. Busse, MD
Allergy, Pulmonary and Critical Care Medicine, Clinical Science Center 600 Highland Ave, Madison, WI USA
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
Ciudad de Buenos Aire, Argentina

Brazil

Research Site
São Paulo, Brazil

Bulgaria

Research Site
Rousse, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Varna, Bulgaria

Germany

Research Site
Hamburg, Germany
Research Site
Mainz, Germany

Poland

Research Site
Bydgoszcz, Poland
Research Site
Giżycko, Poland
Research Site
Lodz, Poland
Research Site
Lubin, Poland
Research Site
Ostrów Wielkopolski, Poland
Research Site
Warsaw, Poland
Research Site
Wroclaw, Poland
Research Site
Żnin, Poland

Russia

Research Site
Chelyabinsk, Russia
Research Site
Izhevsk, Russia
Research Site
Kazan', Russia
Research Site
Moscow, Russia
Research Site
Novosibirsk, Russia
Research Site
Pyatigorsk, Russia
Research Site
Saint Petersburg, Russia
Research Site
Ulyanovsk, Russia
Research Site
Vladikavkaz, Russia
Research Site
Yekaterinburg, Russia

United States

Research Site
Birmingham, Alabama, United States
Research Site
Glendale, Arizona, United States
Research Site
San Jose, California, United States
Research Site
Centennial, Colorado, United States
Research Site
Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
Winter Park, Florida, United States
Research Site
Lawrenceville, Georgia, United States
Research Site
Savannah, Georgia, United States
Research Site
Bellevue, Nebraska, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Pittsburgh, Pennsylvania, United States

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2013
Primary completion: 31 Jul 2014
Completion: 31 Jul 2014
Last update posted: 24 Nov 2015
Registered enrollment: 13
Registry id: NCT01947946

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.